STLN compared with TOI: revenue, margins and what each company keeps, and the suppliers and customers both name

STLNStarling Oncology, Inc.

Mkt capRevenueRevenue

TOIOncology Institute, Inc.

Mkt capRevenueRevenue

Compare

STLNStarling Oncology, Inc.

TOIOncology Institute, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

STLNStarling Oncology, Inc.

6.28▲+0.41%

Mkt cap$665.5MRevenue$161MQ2 FY26Revenue$503MFY25

TOIOncology Institute, Inc.

6.28▲+0.41%

Regular sessionNov 3 '26

Mkt cap$637.0MRevenue$161MQ2 FY26Revenue$503MFY25

Compare

Regular sessionNov 3 '26

STLNStarling Oncology, Inc.

TOIOncology Institute, Inc.

6.28▲+0.41%

Price

6.28▲+0.41%

$665.5M

Mkt cap

$637.0M

Q2 FY26$161M

Revenue

$161MQ2 FY26

FY25$503M

Revenue

$503MFY25

STLN6.28▲+0.41%vsTOI6.28▲+0.41%Regular sessionNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

STLN: latest quarter is a loss; flow not drawable. TOI: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only STLN 0

None

Shared 0

No disclosed counterparties: STLN.

Only TOI 8

UNHOptum Carecustomer

ELVAnthemcustomer

—Helios CRunlistedsupplier

—Change Healthcareunlistedsupplier

4 more · TOI chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

STLN, solidTOI, dashed